Beam Therapeutics
BEAM
#3865
Rank
$3.51 B
Marketcap
$34.14
Share price
5.11%
Change (1 day)
104.31%
Change (1 year)

Beam Therapeutics (BEAM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.31 Billion USD

According to Beam Therapeutics 's latest financial reports the company's total liabilities are $0.31 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Beam Therapeutics - Total liabilities on balance sheet (from 2018 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.24 B-34.42%
2024-12-31$0.37 B-22.6%
2023-12-31$0.47 B-21.35%
2022-12-31$0.60 B-6.09%
2021-12-31$0.64 B214.25%
2020-12-31$0.20 B273.71%
2019-12-31$55.15 M67.21%
2018-12-31$32.98 M400.9%
2017-12-31$6.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
$24.52 M-92.25%๐Ÿ‡บ๐Ÿ‡ธ USA